Latest Immunologic tests Stories
BILLERICA, Mass., May 22, 2015 /PRNewswire/ -- BioScale, Inc., a leading supplier of novel protein measurement technology to accelerate the development of diagnostic and clinical applications,
DALLAS, May 18, 2015 /PRNewswire/ -- According to a new market research report "Immunoassay Market by Technology (ELISA, Fluorescence, Colorimetric, Chemiluminescence,
BRISBANE, Australia, April 28, 2015 /PRNewswire/ -- Anteo Technologies is transforming the way scientists work by providing powerful new tools developed with their patented Mix&Go(TM) Activation
PASADENA, Calif., April 20, 2015 /PRNewswire/ -- Meditope Biosciences, Inc., a biotechnology company developing novel antibody-based
SAN DIEGO, April 10, 2015 /PRNewswire/ -- Inova Diagnostics, the worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, announced today that
RnRMarketResearch.com adds “Blood Screening Market by Technology (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting),
The blood screening market by technology includes nucleic acid tests (NAT), enzyme-linked immunosorbent assays (ELISA), enzyme immunoassays (EIAs) and chemiluminescent immunoassays (CLIAs), next-generation
Comprehensive epigenetic services are now offered by Epigentek, including Methyl-Seq genome-wide DNA methylation (5-mC) analysis, chromatin immunoprecipitation sequencing (ChIP-Seq), and commercialized
NEW YORK and VANCOUVER, British Columbia, March 5, 2015 /PRNewswire/ -- BioMark Diagnostics (CSE: BUX FSE: 20B OTCQB: BMKDF) -- The ultimate goal in the cancer diagnostics sector is to establish an
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.